APA (7th ed.) Citation

Y, C., K, R., MRA, K., CF, P., Z, G., S, Y., . . . C, M. (2026). Anti-CAR Immunity Drives Acquired Therapeutic Resistance to GD2-CAR T Cell Therapy in Diffuse Midline Glioma. MedRxiv : the preprint server for health sciences. https://doi.org/10.64898/2026.06.25.26356492

Chicago Style (17th ed.) Citation

Y, Chen, et al. "Anti-CAR Immunity Drives Acquired Therapeutic Resistance to GD2-CAR T Cell Therapy in Diffuse Midline Glioma." MedRxiv : The Preprint Server for Health Sciences 2026. https://doi.org/10.64898/2026.06.25.26356492.

MLA (9th ed.) Citation

Y, Chen, et al. "Anti-CAR Immunity Drives Acquired Therapeutic Resistance to GD2-CAR T Cell Therapy in Diffuse Midline Glioma." MedRxiv : The Preprint Server for Health Sciences, 2026, https://doi.org/10.64898/2026.06.25.26356492.